Kapiva Launches $6M Fund for Ayurvedic Medical Research

Kapiva, a leading Ayurvedic wellness brand in India, has launched a Rs 50 crore (approximately $6 million) innovation fund to bridge the gap between ancient healing traditions and modern medical standards.

The Kapiva Innovation Fund will support researchers, universities, labs, and startups working to develop clinically validated Ayurvedic treatments. It's a bet that traditional medicine can stand shoulder to shoulder with conventional pharmaceuticals if tested with the same scientific discipline.

"For decades, Ayurveda has been seen as either faith-based or purely traditional wisdom," said Ameve Sharma, Kapiva's founder. "We believe its future lies in being outcome-led and evidence-backed."

The fund targets specific scientific frontiers. Researchers can apply for support developing new formulations, standardizing plant chemistry, applying artificial intelligence to traditional treatments, and conducting clinical trials. The company will also back advanced extraction technologies and bioactive enhancement methods that could make traditional remedies more effective.

Kapiva isn't just writing checks. Selected projects will receive mentorship, access to clinical resources, and infrastructure support to help transform early-stage research into real-world medical solutions.

The Ripple Effect

This initiative could reshape how the world views traditional medicine systems. By demanding the same rigorous testing required of modern drugs, Kapiva is building credibility for remedies that have been used for thousands of years but often dismissed by mainstream medicine.

The fund is already accepting applications from researchers, clinicians, institutions, and entrepreneurs. A panel combining Kapiva's research leadership and outside experts will evaluate proposals, looking for high-potential ideas at any stage from early research to near-commercialization.

"If Ayurveda has to sit at the same table as modern medicine, it must be tested with the same discipline," said R Govindarajan, Kapiva's Chief Innovation Officer. The fund aims to create an ecosystem where traditional knowledge meets contemporary scientific standards without losing its cultural roots.

For patients worldwide seeking alternatives to conventional treatments, this could mean access to ancient remedies backed by modern proof.